161 related articles for article (PubMed ID: 36358711)
1. Modified Albumin-Bilirubin Grade and Alpha-Fetoprotein Score (mALF Score) for Predicting the Prognosis of Hepatocellular Carcinoma after Hepatectomy.
Kaibori M; Yoshii K; Matsui K; Matsushima H; Kosaka H; Yamamoto H; Aoi K; Yamaguchi T; Yoshida K; Hatanaka T; Hiraoka A; Tada T; Kumada T; Sekimoto M
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358711
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a modified albumin-bilirubin grade and α-fetoprotein score (mALF score) for hepatocellular carcinoma patients receiving atezolizumab and bevacizumab.
Hatanaka T; Kakizaki S; Hiraoka A; Tada T; Hirooka M; Kariyama K; Tani J; Atsukawa M; Takaguchi K; Itobayashi E; Fukunishi S; Tsuji K; Ishikawa T; Tajiri K; Ochi H; Yasuda S; Toyoda H; Ogawa C; Nishimura T; Shimada N; Kawata K; Kosaka H; Tanaka T; Ohama H; Nouso K; Morishita A; Tsutsui A; Nagano T; Itokawa N; Okubo T; Arai T; Imai M; Naganuma A; Koizumi Y; Nakamura S; Kaibori M; Iijima H; Hiasa Y; Kumada T;
Hepatol Int; 2023 Feb; 17(1):86-96. PubMed ID: 36076009
[TBL] [Abstract][Full Text] [Related]
3. The Role of the Albumin-Bilirubin Score for Predicting the Outcomes in Japanese Patients with Advanced Hepatocellular Carcinoma Treated with Ramucirumab: A Real-World Study.
Hatanaka T; Naganuma A; Shibasaki M; Kohga T; Arai Y; Nagashima T; Ueno T; Namikawa M; Saito S; Hoshino T; Takizawa D; Arai H; Makita F; Kakizaki S; Harimoto N; Shirabe K; Uraoka T
Oncology; 2021; 99(4):203-214. PubMed ID: 33279908
[TBL] [Abstract][Full Text] [Related]
4. A novel combined C-reactive protein-albumin ratio and modified albumin-bilirubin score can predict long-term outcomes in patients with hepatocellular carcinoma after hepatic resection.
Aida T; Haruki K; Akaoka M; Furukawa K; Onda S; Shirai Y; Shiozaki H; Takahashi K; Oikawa T; Ikegami T
Ann Gastroenterol Surg; 2024 Jan; 8(1):143-150. PubMed ID: 38250682
[TBL] [Abstract][Full Text] [Related]
5. Proposal of an integrated staging system using albumin-bilirubin grade and serum alpha-fetoprotein values for predicting postoperative prognosis of recurrent hepatocellular carcinoma.
Matsumoto T; Shiraki T; Niki M; Sato S; Tanaka G; Shimizu T; Yamaguchi T; Park KH; Mori S; Iso Y; Ishizuka M; Kubota K; Aoki T
Eur J Surg Oncol; 2024 Jun; 50(6):108356. PubMed ID: 38685177
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of Tumor Marker Score for Predicting the Prognosis of Hepatocellular Carcinoma Patients Treated with Atezolizumab Plus Bevacizumab: A Multicenter Retrospective Study.
Tanaka K; Tsuji K; Hiraoka A; Tada T; Hirooka M; Kariyama K; Tani J; Atsukawa M; Takaguchi K; Itobayashi E; Fukunishi S; Ishikawa T; Tajiri K; Ochi H; Toyoda H; Ogawa C; Nishimura T; Hatanaka T; Kakizaki S; Shimada N; Kawata K; Naganuma A; Kosaka H; Matono T; Kuroda H; Yata Y; Ohama H; Tada F; Nouso K; Morishita A; Tsutsui A; Nagano T; Itokawa N; Okubo T; Arai T; Yokohama K; Nishikawa H; Imai M; Koizumi Y; Nakamura S; Iijima H; Kaibori M; Hiasa Y; Kumada T;
Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686624
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the New Neo-Glasgow Prognostic Score Based on the Albumin-Bilirubin Grade with Currently Used Nutritional Indices for Prognostic Prediction following Surgical Resection of Hepatocellular Carcinoma: A Multicenter Retrospective Study in Japan.
Kaibori M; Hiraoka A; Iida H; Komeda K; Hirokawa F; Ueno M; Kosaka H; Matsui K; Sekimoto M
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565221
[TBL] [Abstract][Full Text] [Related]
8. A detailed assessment of liver function in patients with hepatocellular carcinoma via the modified albumin-bilirubin (mALBI) grade.
Zhong CR; Qiu JL; Yuan YC; Qiu ZY; Li K; Wang CW; Shi YX; Li KR; Lin Z; Huang ZK; He W; Li BK; Yuan YF
Am J Cancer Res; 2022; 12(6):2711-2720. PubMed ID: 35812041
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of a Modified Albumin-Bilirubin Score Designed for Patients with Esophageal Squamous Cell Carcinoma After Radical Resection.
Shinozuka T; Kanda M; Shimizu D; Tanaka C; Inokawa Y; Hattori N; Hayashi M; Koike M; Kodera Y
Ann Surg Oncol; 2022 Aug; 29(8):4889-4896. PubMed ID: 35381933
[TBL] [Abstract][Full Text] [Related]
10. Modified Albumin-Bilirubin Model for Stratifying Survival in Patients with Hepatocellular Carcinoma Receiving Anticancer Therapy.
Hsu WF; Hsu SC; Chen TH; Lin CH; Lin YC; Chang YW; Wang HW; Liao YM; Lai HC; Peng CY
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291867
[TBL] [Abstract][Full Text] [Related]
11. Modified Child-Pugh grade
Huang F; Gao J
World J Gastroenterol; 2020 Feb; 26(7):749-758. PubMed ID: 32116422
[TBL] [Abstract][Full Text] [Related]
12. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
[No Abstract] [Full Text] [Related]
13. Chronological change in serum albumin as a prognostic factor in patients with hepatocellular carcinoma treated with lenvatinib: proposal of albumin simplified grading based on the modified albumin-bilirubin score (ALBS grade).
Kariyama K; Hiraoka A; Kumada T; Yasuda S; Toyoda H; Tsuji K; Hatanaka T; Kakizaki S; Naganuma A; Tada T; Takaguchi K; Itobayashi E; Ishikawa T; Shimada N; Tsutsui A; Nagano T; Imai M; Nakamura S; Wakuta A; Miyake N; Shiota S; Nouso K
J Gastroenterol; 2022 Aug; 57(8):581-586. PubMed ID: 35763116
[TBL] [Abstract][Full Text] [Related]
14. The ALBI Grade is a Good Predictive Model for Very Late Recurrence in Patients with Hepatocellular Carcinoma Undergoing Primary Resection.
Lin CY; Lin CC; Wang CC; Chen CL; Hu TH; Hung CH; Huang PY; Tsai MC
World J Surg; 2020 Jan; 44(1):247-257. PubMed ID: 31559485
[TBL] [Abstract][Full Text] [Related]
15. Surgical Outcomes for Hepatocellular Carcinoma in Patients with Child-Pugh Class B: a Retrospective Multicenter Study.
Tanaka S; Noda T; Komeda K; Kosaka H; Iida H; Ueno M; Hokuto D; Ikoma H; Nakai T; Kabata D; Shinkawa H; Kobayashi S; Hirokawa F; Mori H; Hayami S; Morimura R; Matsumoto M; Ishizawa T; Kubo S; Kaibori M
J Gastrointest Surg; 2023 Feb; 27(2):283-295. PubMed ID: 36471191
[TBL] [Abstract][Full Text] [Related]
16. Modified Albumin-Bilirubin Grade optimized for risk stratification of patients with stage II-III gastric cancer.
Shoka M; Kanda M; Ito S; Mochizuki Y; Teramoto H; Ishigure K; Murai T; Asada T; Ishiyama A; Matsushita H; Shimizu D; Tanaka C; Fujiwara M; Murotani K; Kodera Y
Surg Today; 2023 Oct; 53(10):1149-1159. PubMed ID: 36961609
[TBL] [Abstract][Full Text] [Related]
17. The role of preoperative albumin-bilirubin grade for oncological risk stratification in liver transplant patients with hepatocellular carcinoma.
Kornberg A; Witt U; Schernhammer M; Kornberg J; Müller K; Friess H; Thrum K
J Surg Oncol; 2019 Dec; 120(7):1126-1136. PubMed ID: 31578753
[TBL] [Abstract][Full Text] [Related]
18. Long-term Outcomes and Prognostic Factors of Stereotactic Body Radiotherapy for Hepatocellular Carcinoma.
Nagata K; Sasaki R; Iwatsu S; Fukushima M; Haraguchi M; Yamamichi S; Miuma S; Miyaaki H; Taura N; Yamazaki T; Nakao K
Anticancer Res; 2022 Oct; 42(10):5001-5007. PubMed ID: 36192013
[TBL] [Abstract][Full Text] [Related]
19. Nomogram Based on Platelet-Albumin-Bilirubin for Predicting Tumor Recurrence After Surgery in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma Patients.
Yang C; Wu X; Liu J; Wang H; Jiang Y; Wei Z; Cai Q
J Hepatocell Carcinoma; 2023; 10():43-55. PubMed ID: 36660412
[TBL] [Abstract][Full Text] [Related]
20. The combination of the preoperative albumin-bilirubin grade and the fibrosis-4 index predicts the prognosis of patients with hepatocellular carcinoma after liver resection.
Zhang J; Luo Y; Li C; Liu J; Xiang H; Wen T
Biosci Trends; 2019; 13(4):351-357. PubMed ID: 31527331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
